XML 97 R87.htm IDEA: XBRL DOCUMENT v3.20.2
Note 24 - Share-based Compensation Expenses (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 28, 2020
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Dec. 31, 2020
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2022
Dec. 31, 2021
Share Price (in dollars per share)     $ 1.11            
Share-based Payment Arrangement, Expense   $ 68   $ 102   $ 1,987 $ 203    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total   420       420      
Forecast [Member]                  
Share-based Payment Arrangement, Expense         $ 140     $ 40 $ 240
Restricted Stock [Member] | Director [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     430,000            
Share Price (in dollars per share)     $ 1.11            
Management Consulting and Advisor Service Term (Year)     2 years            
Restricted Stock [Member] | Management Consulting and Advisor Service Providers [Member]                  
Share-based Payment Arrangement, Expense   60       80      
Issuance of Stock and Warrants for Services or Claims     $ 480            
The 2015 Omnibus Securities and Incentive Plan [Member] | Restricted Stock [Member]                  
Share-based Payment Arrangement, Expense   $ 10       20      
The 2015 Omnibus Securities and Incentive Plan [Member] | Restricted Stock [Member] | Management and Employees [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 1,600,000                
Share Price (in dollars per share) $ 1.18                
Share-based Payment Arrangement, Expense           $ 1,890      
The 2015 Omnibus Securities and Incentive Plan [Member] | Restricted Stock [Member] | Unrelated Service Provider [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)     30,000